$CPRX Catalyst Pharmaceutical: Roth Capital Analyst Sees 85% Probability Of US Approval For Firdapse http://www.smarteranalyst.com/2014/09/30/catalyst-pharmaceutical-roth-capital-sees-85-probability-us-approval-firdapse/